Publication | Open Access
Combination therapy of chemokine receptor inhibition plus PDL-1 blockade potentiates anti-tumor effects in a murine model of breast cancer
18
Citations
0
References
2015
Year
Breast OncologyImmunologyPharmacotherapyT CellsTumor BiologyTumor ImmunologyOncologyTumor ImmunityAbstracts TraffickingAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyTumor MicroenvironmentImmune SuppressionPdl-1 BlockadeCancer ImmunosurveillanceImmune Checkpoint InhibitorBreast CancerCombination TherapyCellular Immune ResponseMedicine
Meeting abstracts Trafficking and expansion of myeloid derived suppressor cells (MDSCs) plays a major role in immune suppression of tumor. MDSCs express chemokine receptors which likely mediate their recruitment to the tumor microenvironment. Suppression of T cells is also mediated by the